Yunsheng (Tony) Hsieh

Yunsheng (Tony) Hsieh has been working in the pharmaceutical industry since 1998. Yunsheng (Tony) began their career at the Schering-Plough Research Institute as a Senior Principal Scientist and then moved to Merck in 2009, where they held the same role. In 2011, Hsieh joined HD Biosciense as a Senior Director of DMPK/Bioanalytical, and also began working at BioDuro as a Director of Bioanalytical/DMPK. Yunsheng (Tony) then moved to Novotech in 2012 as a Chief Scientific Officer/Consultant before joining Aria Pharmaceuticals in 2021 as the DMPK Head.

Yunsheng (Tony) Hsieh's education history includes a Ph.D. in Chemistry from Michigan State University in 1994, a Postdoc in the Department of Pharmacology from the University of Florida in 1996, and a Postdoc in the Department of Pharmaceutical Sciences from the University of California, San Francisco in 1998. Yunsheng (Tony) also attended Tsinghua University for Nuclear Sciences.